Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1

ANB Capital forecasts Q3 profit growth for Dr. Sulaiman Al Habib stock

Published on 10/12/2026 at 09:08 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Q3 earnings are seen at SAR 651.90 million, up 8.20 percent year over year. For Dr. Sulaiman Al Habib stock, H1 profit was SAR 1.16 billion.

Key points in brief

ANB Capital estimates third-quarter 2026 net profit at SAR 651.90 million, up 8.20 percent year over year.
First-half 2026 net income reached SAR 1.16 billion, with second-quarter profit at SAR 662.70 million.
BSF Capital set a SAR 240.00 target and assigned a Hold rating on September 20, 2026.
The company expanded its healthcare network through The Red Sea Hospital opening on September 17, 2026.

Dr. Sulaiman Al Habib Medical Services, SA1510P1UMH1, Illustration mit AI erstellt.

ANB Capital estimated Dr. Sulaiman Al Habib Medical Services Group Company third-quarter 2026 net income at SAR 651.90 million, up 8.20 percent year over year, in an October 11, 2026 forecast published by Argaam. The estimate gives the latest measurable earnings signal for Dr. Sulaiman Al Habib stock and puts operating growth ahead of the wider healthcare debate.

Three developments shape the story

On July 26, 2026, the company announced a second-quarter cash dividend of SAR 465.50 million, according to Argaam. The same company data show first-half 2026 net income of SAR 1.16 billion and second-quarter profit of SAR 662.70 million.

On September 17, 2026, Dr. Sulaiman Al Habib opened The Red Sea Hospital in partnership with Red Sea Global. The facility provides emergency, inpatient, outpatient and specialized care, while the planned healthcare network includes six pharmacies, as PR Newswire reported on September 21, 2026.

On October 11, 2026, the ANB Capital estimate became the newest dated operating marker. The SAR 651.90 million forecast is below the SAR 662.70 million second-quarter actual result, but it remains 8.20 percent above the comparable prior-year quarter.

What does the target imply?

BSF Capital assigned a Hold rating and a SAR 240.00 target on September 20, 2026, according to Argaam. The target frames valuation as a separate issue from the earnings trajectory, leaving investors to weigh forecast growth against the cautious rating.

Saudi listing and market context

Dr. Sulaiman Al Habib Medical Services Group Company trades under ticker 4013.SR on Tadawul and carries the ISIN SA1510P1UMH1, according to Global Banking and Finance Review. The finance profile classifies the business in Healthcare and Medical - Care Facilities, with a market capitalization of SAR 79.7 billion as of October 11, 2026.

Market context: Latest market reports.